The author reports a new technique of balanced anaesthesia using a pump-controlled 0.1% solution of Tramadol instead of the inhalation of halothane, enflurane or infusion of neuroleptanalgetic agents. Tramadol (Tramal) is a new analgetic drug without side effects: no postnarcotic respiratory depression, sickness or vomiting do not occur, and it does not interfere with the cardiovascular system. The other great advantage is the ultrashort recovery of the patient, mostly with 30-60 s, even after long lasting surgical procedures over several hours. The author has been convinced for more than 15 years that the future of anaesthesia no longer lies in the inhalation of chloroformoids, but in the infusion of analgesic substances. His experience has shown that the analgesic drug Tramadol, which has practically no side-effects, is a considerable advance into this direction. Last but not least this also applies to the prompt post-anaesthetic recovery and the absence of postoperative complications. This technique has been used in the last two years in 7500 patients, So far we have not seen an contraindications to Tramadol infusion. On the contrary, the greater the risk, the more this form of anaesthesia was found to be indicated.

Download full-text PDF

Source

Publication Analysis

Top Keywords

[infusion-controlled tramal-anaesthesia
4
tramal-anaesthesia author's
4
author's transl]
4
transl] author
4
author reports
4
reports technique
4
technique balanced
4
balanced anaesthesia
4
anaesthesia pump-controlled
4
pump-controlled 01%
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!